McMaster lab to screen for rare antibody that causes blood clots after AstraZeneca vaccination

A team of doctors at Hamilton's McMaster University will conduct tests on blood samples from potential Canadian patients in search of a rare type of clot linked to the Astra-Zeneca COVID-19 vaccine.